Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts (NASDAQ:GNLX)08/30/2024 sutthirat sutthisumdang Roth MKM started protection of Genelux (NASDAQ:GNLX) with a buy score, citing the corporate’s drug Olvi-Vec within the remedy of ovarian most cancers. The…
